Washington D.C.’s most powerful drug industry trade group this week again took aim at hospitals’ use of 340B savings, while [...] …
Pharma Industry
A Japanese pharmaceutical giant this week announced that it has added a blood cancer treatment to its list of drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
Pharmaceutical giant Johnson & Johnson (J&J) recently announced it will soon expand its 340B claims data requirements to include in-house [...] …
Please Login or Become a Paid Subscriber to View this Content
Editor’s Note: As the 340B program draws increased attention from researchers, policymakers and commentators, 340B Report has launched a new [...] …
Please Login or Become a Paid Subscriber to View this Content
A key hospital trade group accused drugmakers of holding 340B discounts “hostage” and rewriting program rules to “line their pockets” [...] …
Please Login or Become a Paid Subscriber to View this Content
A Colorado federal judge on Tuesday dismissed a drug industry trade group’s lawsuit against the state’s 340B access law—one day [...] …
Please Login or Become a Paid Subscriber to View this Content
Pharmaceutical manufacturers AbbVie and Organon recently announced new state exemptions to their 340B contract pharmacy restrictions following legal developments in [...] …
Please Login or Become a Paid Subscriber to View this Content
HRSA has contacted certain 340B providers about agreements with their contract pharmacies that could be released to French drugmaker Sanofi [...] …
Please Login or Become a Paid Subscriber to View this Content
A Colorado federal judge on Monday dismissed U.K.-based drugmaker AstraZeneca’s challenge to the state’s 340B access law, handing another legal [...] …
Please Login or Become a Paid Subscriber to View this Content
340B stakeholders recently urged U.S. Sen. Bill Cassidy (R-La.) to make changes to his draft 340B reform legislation, with provider [...] …
